Key result
Elevated Lp(a) is linked to ~33% higher risk of repeat revascularization after PCI.
Why the study?
Do elevated Lipoprotein(a) levels increase the risk of repeat revascularization in patients after percutaneous coronary intervention?
Meta-Analysis
Do elevated Lipoprotein(a) levels increase the risk of repeat revascularization in patients after percutaneous coronary intervention?
Answers are grounded in this paper and cite their sources.
Elevated lipoprotein(a) levels are significantly associated with an increased risk of repeat revascularization and target vessel revascularization following percutaneous coronary intervention.
BACKGROUND: Lipoprotein(a) (Lp(a)) is a proatherogenic lipoprotein associated with increased cardiovascular risk and is minimally responsive to statins or lifestyle changes. While Lp(a) is linked to adverse cardiovascular events, its role in predicting repeat revascularization after percutaneous coronary intervention (PCI) remains unclear. This review evaluates the relationship between Lp(a) levels and coronary revascularization outcomes. METHODS: statistic and Cochran's Q test, and publication bias was evaluated with Egger's regression test. RESULTS: Twenty studies were included in the systematic review, of which eighteen were included in the meta-analysis. Elevated Lp(a) levels were associated with a higher risk of any repeat revascularization, with pooled OR 1.33 (95% CI: 1.17-1.52) and HR 1.15 (95% CI: 1.05-1.25). High Lp(a) was also linked to increased risk of target vessel revascularization (TVR) (OR 1.42; 95% CI: 1.12-1.81). A non-significant trend towards increased target lesion revascularization (TLR) was observed (OR 1.25; 95% CI: 0.96-1.64). CONCLUSION: Elevated Lp(a) levels were associated with a higher risk of repeat revascularization and TVR, with a non-significant trend towards increased TLR. Further studies are warranted to confirm these findings and explore the potential benefit of Lp(a)-lowering strategies.
No takes yet. Share an insight, caveat, or question.
Srikulmontri et al. (2026) conducted a meta-analysis in Percutaneous coronary intervention (PCI). Elevated Lipoprotein(a) levels vs. Lower Lipoprotein(a) levels was evaluated on Any repeat revascularization (OR 1.33, 95% CI 1.17-1.52). Elevated Lipoprotein(a) levels were associated with a higher risk of any repeat revascularization after percutaneous coronary intervention.
Synapse has enriched 10 related papers. Consider them for comparative context: